# FDA_510k Prediction Engine: Forecasting Device Submissions via Patent Signals

> **Problem**: Investors and manufacturers are blind to future FDA submissions. Patent filings are an early signal—but nobody connects them.

**FDA_510k Prediction Engine solves this** by forecasting FDA device submissions 3-5 years forward using patent filing trends as leading indicators. Patent clusters today → device approvals tomorrow.

---

## The Insight

**Patent filings precede FDA submissions by 2-4 years.**

Companies file patents to protect IP, then commercialize via FDA 510k submissions. This lag is:
- **Measurable** (discovered from historical data, not assumed)
- **Category-specific** (cardiac monitoring: 2.1yr lag, diagnostics: 1.5yr lag)
- **Quantified** (with uncertainty bands: ± std dev)

By analyzing *where patents cluster now*, forecast *where device approvals will follow*.

```
2023-2024: Heavy patents in "AI-powered cardiac monitoring"
   ↓ (lag: 2.1 years ± 0.8)
2025-2026: Patent cluster intensity plateaus (signal mature)
   ↓
2026-2027: Predict surge in cardiac monitoring 510k submissions
   ↓ (backtest validates prediction)
2027-2028: Monitor actual FDA approvals, track error, recalibrate
```

---

## How It Works

```
Patent Data (4.5M from patent_review)
    ↓
[Extract Cluster Features]
├─ Domain (CPC category)
├─ Volume (filing count)
├─ Growth rate (year-over-year)
├─ Top filers (who's investing)
└─ Velocity (accelerating vs. plateau)
    ↓
[Discover Lag Distribution]
├─ Historical alignment: cluster → 510k submission (2017-2025)
├─ Measure delay: submission date - cluster filing date
├─ Build lag distribution per category (median ± std dev)
└─ Extract category-specific profile
    ↓
[Time-Series Forecasting]
├─ Fit ARIMA/Prophet per device category
├─ Features: patent volume, cluster intensity
├─ Predict 2026-2029 510k submissions
├─ Output: point estimate + uncertainty bands
    ↓
[Blind Backtesting]
├─ Train on 2015-2021 data (patents + historical 510ks)
├─ Test on 2022-2025 (held-out submissions)
├─ Score: MAE, MAPE, category-specific accuracy
├─ Publish: "Cardiac: MAE=15, Diagnostics: MAE=45"
    ↓
[Forecast Delivery]
├─ Investor thesis: "Cardiac monitoring surge 35% in 2027"
├─ Regulatory foresight: "340 ± 30 submissions, breakdown by class"
├─ Tracking error: "Our 2024-forecast 2027 volume: actual vs. predicted"
```

---

## Why This Architecture Matters

### 1. Data-Driven Lag Discovery (Not Assumptions)

You don't assume "2-year lag." You extract it from historical data:

```python
def align_patents_to_510k():
    for submission in fda_submissions_2017_2025:
        cluster = find_nearest_cluster(submission.category)
        lag = submission.date - cluster.filing_date
        record_lag(lag)
    
    lag_distribution = stats(all_lags)  # median, std, quantiles
```

**Why this matters**: Different device categories have different lags. Cardiac monitoring ≠ diagnostics. This is discovered from data.

### 2. Time-Series Forecasting (Not Binary Classification)

Not "yes/no, will we see devices?" But "how many" and "when" with uncertainty:

```json
{
  "category": "Cardiac Monitoring",
  "forecast_2027": {
    "point_estimate": 340,
    "model_ci": [320, 360],
    "lag_ci": [310, 370],
    "conservative": 280,
    "aggressive": 400
  }
}
```

Investors get range, not point. Regulators see breakdown by device class.

### 3. Rigorous Backtesting (Blind Hindcasting)

- Train on 2015-2021 (historical patent + 510k data)
- Test on 2022-2025 (held-out real submissions)
- Score: MAE, MAPE, segment by category
- Honest: "Diagnostics forecasts poorly (MAE=45); likely noise."

**Why this matters**: You don't ship a forecast tool without knowing its accuracy.

### 4. Continuous Recalibration

Every quarter:
- Ingest new 510k submissions (from FDA database)
- Update historical alignment (patent ↔ 510k lag)
- Retrain models
- Compare new forecast to prior quarter's 2027 prediction
- Publish tracking error

**Why this matters**: Real data updates beliefs. If lag was 2.1yr and actual is 2.3yr, you detect it and adapt.

---

## Tech Stack

| Layer | Technology | Why |
|-------|-----------|-----|
| **Data Source** | Patent_review artifact (HDBSCAN clusters) | Reuses existing patent clustering |
| **Lag Discovery** | Python data alignment | Extract lag distribution from history |
| **Forecasting** | ARIMA / Prophet / LSTM | Time-series models per category |
| **Backtesting** | Cross-validation (train/test split) | Blind hindcasting for accuracy |
| **Uncertainty** | Multiple bands (model CI, lag CI, external scenarios) | Honest about where uncertainty comes from |
| **Output** | JSON forecasts | Investor briefings + regulatory exports |

---

## Architecture Decisions

See [ARCHITECTURE_DECISIONS.md](ARCHITECTURE_DECISIONS.md) for detailed ADRs covering:

- ADR-1: Leverage patent landscape clustering (upstream signal)
- ADR-2: Time-series forecasting (not static classification)
- ADR-3: Historical alignment via "patent lag" window
- ADR-4: Backtesting (blind hindcasting)
- ADR-5: Reuse patent_review's clustering (single source of truth)
- ADR-6: Multi-layer uncertainty (not point predictions)
- ADR-7: Multiple output formats (investor vs. regulatory)
- ADR-8: Continuous recalibration (streaming 510k approvals)

---

## For Technical Interviews

**Key questions**:

1. **"Why is patent filing a better signal than market research surveys?"**
   - Patents are behavioral (companies invest). Surveys are opinion.

2. **"You backtest on 2022-2025. How do you know your accuracy will hold in 2026?"**
   - Quarterly recalibration + tracking error publication. Adapt if patterns shift.

3. **"Lag is normally distributed. What if it's bimodal?"**
   - Tests: Do you know your assumptions? Can you detect when they break?

4. **"Your forecast is wrong. How do you debug time-series models?"**
   - Tests: Do you understand model failure modes?

5. **"Patent-to-FDA lag is 2.1 years. What invalidates this assumption?"**
   - Acquired tech (no internal R&D), regulatory changes, market disruption.

---

## Full Code

**This repository contains architecture and design philosophy.** Full source code is private.

For technical interviews, I can grant read-only access:
- Complete Python lag-discovery pipeline
- Time-series forecasting models (ARIMA, Prophet, LSTM)
- Backtesting framework
- Historical FDA data alignment
- Quarterly recalibration scripts
- Reporting templates (investor + regulatory)

**Contact**: yow.stephend@gmail.com

---

## Development Approach

Architected and designed by me. Implementation accelerated with Claude as an AI design/coding partner.

This demonstrates: building leading-indicator systems that connect upstream signals (patent filings) to downstream outcomes (FDA approvals). Data-driven hypothesis discovery, uncertainty quantification, and continuous validation.

---

**Status**: In active development (quarterly forecasts published)  
**Data**: 4.5M patents via patent_review + FDA 510k database (historical alignment)  
**Forecast Horizon**: 3-5 years forward  
**Update Cadence**: Quarterly (as new 510k submissions arrive)
